Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
EBITDA Margin
19.88%
TTM · Period ending:
BIO EBITDA Margin
Latest reported19.88%period ending
Latest reported19.88%period ending
BIO TTM EBITDA Margin (17.89% → 19.88%)
TTM ebitda margin
High-resolution chart · PNG
BIO ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 19.878% | |
| 16.9814% | |
| 46.8373% | |
| -24.2935% | |
| 26.0744% | |
| -99.9112% | |
| -83.0652% | |
| -31.2577% | |
| -59.7989% | |
| -9.4838% | |
| -24.5114% | |
| 0.3767% | |
| -12.2031% | |
| -2.1953% | |
| -161.4546% | |
| -273.5135% | |
| -85.4624% | |
| -3.0176% | |
| 190.7071% | |
| 291.8809% | |
| 186.2737% | |
| 202.1607% | |
| 199.0708% | |
| 195.6528% | |
| 114.9806% | |
| 92.7065% | |
| 103.285% | |
| 29.4257% | |
| 59.6381% | |
| 40.8756% | |
| 29.4624% | |
| 76.8062% | |
| 63.5089% | |
| 50.3489% | |
| 12.4363% | |
| 9.116% | |
| 8.6101% | |
| 9.7959% | |
| 9.9798% | |
| 14.0674% | |
| 14.2371% | |
| 14.6309% | |
| 15.0113% | |
| 14.6353% | |
| 14.507% | |
| 14.9624% | |
| 14.2522% | |
| 14.3624% | |
| 14.3343% | |
| 14.6415% | |
| 15.2008% | |
| 16.0229% | |
| 17.6136% | |
| 18.4332% | |
| 19.6233% | |
| 20.451% | |
| 20.2482% | |
| 19.6283% | |
| 19.7681% | |
| 19.3394% | |
| 19.7791% | |
| 20.1343% | |
| 20.388% | |
| 18.1454% | |
| 17.8899% | |
| 17.7025% | |
| 17.1983% | |
| 16.55% | |
| 15.793% | |
| 15.3339% | |
| 15.2908% | |
| 16.1802% | |
| 15.753% | |
| 14.9162% | |
| 14.3834% | |
| 14.9009% | |
| 14.6593% | |
| 15.4101% | |
| 16.1399% | |
| 16.0767% | |
| 16.0471% | |
| 15.2401% | |
| 14.928% | |
| 15.4949% | |
| 15.822% | |
| 16.5608% | |
| 16.3059% | |
| 16.8952% | |
| 17.5094% | |
| 17.8422% | |
| 18.9056% | |
| 19.2993% | |
| 19.8959% | |
| 19.9521% | |
| 19.6539% | |
| 19.9906% | |
| 19.1656% | |
| 19.0249% | |
| 20.0154% | |
| 18.817% |